BACKGROUND: Preterm prelabor rupture of membranes (PPROM) complicated by microbial invasion of the amniotic cavity (MIAC) leading to histological chorioamnionitis (HCA) significantly impacts perinatal morbidity. Unfortunately, no well-established tool for identifying PPROM patients threatened by these disorders is available. METHODOLOGY/PRINCIPAL FINDINGS: We performed an unbiased exploratory analysis of amniotic fluid proteome changes due to MIAC and HCA. From among the top five proteins that showed the most profound and significant change, we sought to confirm results concerning cathelicidin (P49913, CAMP_HUMAN), since an ELISA kit was readily available for this protein. In our exploratory proteomic study, cathelicidin showed a ∼6-fold higher concentration in PPROM patients with confirmed MIAC and HCA. We verified significantly higher levels of cathelicidin in exploratory samples (women without both MIAC and HCA: median 1.4 ng/ml; women with both conditions confirmed: median 3.6 ng/ml; p = 0.0003). A prospective replication cohort was used for independent validation and for assessment of cathelicidin potential to stratify women with MIAC leading to HCA from women in whom at least one of these conditions was ruled out. We confirmed the association of higher amniotic fluid cathelicidin levels with MIAC leading to HCA (the presence of both MIAC and HCA: median 3.1 ng/ml; other women: median 1.4 ng/ml; p<0.0001). A cathelicidin concentration of 4.0 ng/ml was found to be the best cut-off point for identifying PPROM women with both MIAC and HCA. When tested on the validation cohort, a sensitivity of 48%, a specificity of 90%, a likelihood ratio of 5.0, and an area under receiver-operating characteristic curve of 71% were achieved for identification of women with MIAC leading to HCA. CONCLUSIONS: Our multi-stage study suggests cathelicidin as a candidate marker that should be considered for a panel of amniotic fluid proteins permitting identification of PPROM women with MIAC leading to HCA.

Biomedical Research Center University Hospital Hradec Kralove Hradec Kralove Czech Republic

Zobrazit více v PubMed

Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371:75–84. PubMed PMC

Porreco RP, Heyborne KD, Shapiro H. Amniocentesis in the management of preterm premature rupture of the membranes: a retrospective cohort analysis. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2008;21:573–579. PubMed

Mercer BM, Miodovnik M, Thurnau GR, Goldenberg RL, Das AF, et al. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. JAMA : the journal of the American Medical Association. 1997;278:989–995. PubMed

Ananth CV, Guise JM, Thorp JM., Jr Utility of antibiotic therapy in preterm premature rupture of membranes: a meta-analysis. Obstetrical & gynecological survey. 1996;51:324–328. PubMed

Kenyon SL, Taylor DJ, Tarnow-Mordi W. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. ORACLE Collaborative Group. Lancet. 2001;357:979–988. PubMed

Gopalani S, Krohn M, Meyn L, Hitti J, Crombleholme WR. Contemporary management of preterm premature rupture of membranes: determinants of latency and neonatal outcome. American journal of perinatology. 2004;21:183–190. PubMed

Reeves SA, Gibbs RS, Clark SL. Magnesium for fetal neuroprotection. American journal of obstetrics and gynecology 204: 202 e201–204. 2011. PubMed

Doyle LW. Antenatal magnesium sulfate and neuroprotection. Current opinion in pediatrics. 2012;24:154–159. PubMed

Simhan HN, Canavan TP. Preterm premature rupture of membranes: diagnosis, evaluation and management strategies. BJOG : an international journal of obstetrics and gynaecology. 2005;112:32–37. PubMed

Mercer BM. Preterm premature rupture of the membranes: current approaches to evaluation and management. Obstetrics and gynecology clinics of North America. 2005;32:411–428. PubMed

Mercer BM, Goldenberg RL, Meis PJ, Moawad AH, Shellhaas C, et al. The Preterm Prediction Study: prediction of preterm premature rupture of membranes through clinical findings and ancillary testing. The National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol. 2000;183:738–745. PubMed

Romero R, Quintero R, Oyarzun E, Wu YK, Sabo V, et al. Intraamniotic infection and the onset of labor in preterm premature rupture of the membranes. Am J Obstet Gynecol. 1988;159:661–666. PubMed

Been JV, Zimmermann LJ. Histological chorioamnionitis and respiratory outcome in preterm infants. Archives of disease in childhood Fetal and neonatal edition. 2009;94:F218–225. PubMed

Yoon BH, Romero R, Jun JK, Park KH, Park JD, et al. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. American journal of obstetrics and gynecology. 1997;177:825–830. PubMed

Zanardo V, Vedovato S, Suppiej A, Trevisanuto D, Migliore M, et al. Histological inflammatory responses in the placenta and early neonatal brain injury. Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society. 2008;11:350–354. PubMed

Yoon BH, Park CW, Chaiworapongsa T. Intrauterine infection and the development of cerebral palsy. BJOG : an international journal of obstetrics and gynaecology. 2003;110:124–127. PubMed

Edmondson N, Bocking A, Machin G, Rizek R, Watson C, et al. The prevalence of chronic deciduitis in cases of preterm labor without clinical chorioamnionitis. Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society. 2009;12:16–21. PubMed

Tambor V, Fucikova A, Lenco J, Kacerovsky M, Rehacek V, et al. Application of proteomics in biomarker discovery: a primer for the clinician. Physiol Res. 2010;59:471–497. PubMed

Romero R, Kusanovic JP, Gotsch F, Erez O, Vaisbuch E, et al. Isobaric labeling and tandem mass spectrometry: a novel approach for profiling and quantifying proteins differentially expressed in amniotic fluid in preterm labor with and without intra-amniotic infection/inflammation. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2010;23:261–280. PubMed PMC

Gravett MG, Novy MJ, Rosenfeld RG, Reddy AP, Jacob T, et al. Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. JAMA : the journal of the American Medical Association. 2004;292:462–469. PubMed

The Czech Society of Obstetrics and Gynecology. Clinical Guidelines in Obstetrics. Available in Czech language at. 2007. http://www.perinatologie.cz/dokumenty/

Salafia CM, Weigl C, Silberman L. The prevalence and distribution of acute placental inflammation in uncomplicated term pregnancies. Obstet Gynecol. 1989;73:383–389. PubMed

Tambor V, Hunter CL, Seymour SL, Kacerovsky M, Stulik J, et al. CysTRAQ - A combination of iTRAQ and enrichment of cysteinyl peptides for uncovering and quantifying hidden proteomes. Journal of proteomics. 2012;75:857–867. PubMed

Shilov IV, Seymour SL, Patel AA, Loboda A, Tang WH, et al. The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Molecular & cellular proteomics : MCP. 2007;6:1638–1655. PubMed

Tang WH, Shilov IV, Seymour SL. Nonlinear fitting method for determining local false discovery rates from decoy database searches. Journal of proteome research. 2008;7:3661–3667. PubMed

Frohm Nilsson M, Sandstedt B, Sorensen O, Weber G, Borregaard N, et al. The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infection and immunity. 1999;67:2561–2566. PubMed PMC

Sorensen OE, Follin P, Johnsen AH, Calafat J, Tjabringa GS, et al. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood. 2001;97:3951–3959. PubMed

Yang YH, Zheng GG, Li G, Zhang B, Song YH, et al. Expression of LL-37/hCAP-18 gene in human leukemia cells. Leukemia research. 2003;27:947–950. PubMed

Putsep K, Carlsson G, Boman HG, Andersson M. Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet. 2002;360:1144–1149. PubMed

Chromek M, Slamova Z, Bergman P, Kovacs L, Podracka L, et al. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nature medicine. 2006;12:636–641. PubMed

Nizet V, Ohtake T, Lauth X, Trowbridge J, Rudisill J, et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature. 2001;414:454–457. PubMed

Yoshio H, Tollin M, Gudmundsson GH, Lagercrantz H, Jornvall H, et al. Antimicrobial polypeptides of human vernix caseosa and amniotic fluid: implications for newborn innate defense. Pediatric research. 2003;53:211–216. PubMed

Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. The FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2005;19:1067–1077. PubMed

Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. Journal of immunology. 2004;173:2909–2912. PubMed

Liu PT, Stenger S, Li H, Wenzel L, Tan BH, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311:1770–1773. PubMed

Adorini L, Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nature clinical practice Rheumatology. 2008;4:404–412. PubMed

Amatngalim GD, Nijnik A, Hiemstra PS, Hancock RE. Cathelicidin peptide LL-37 modulates TREM-1 expression and inflammatory responses to microbial compounds. Inflammation. 2011;34:412–425. PubMed

Camargo CA, Jr, Rifas-Shiman SL, Litonjua AA, Rich-Edwards JW, Weiss ST, et al. Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. The American journal of clinical nutrition. 2007;85:788–795. PubMed PMC

McGrath J. Hypothesis: is low prenatal vitamin D a risk-modifying factor for schizophrenia? Schizophrenia research. 1999;40:173–177. PubMed

McGrath J, Saari K, Hakko H, Jokelainen J, Jones P, et al. Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study. Schizophrenia research. 2004;67:237–245. PubMed

Shand AW, Nassar N, Von Dadelszen P, Innis SM, Green TJ. Maternal vitamin D status in pregnancy and adverse pregnancy outcomes in a group at high risk for pre-eclampsia. BJOG : an international journal of obstetrics and gynaecology. 2010;117:1593–1598. PubMed

Stene LC, Joner G. Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study. The American journal of clinical nutrition. 2003;78:1128–1134. PubMed

Arora CP, Hobel CJ. Vitamin D - a novel role in pregnancy. Biopolymers and Cell. 2010;26:8.

Wu WK, Wang G, Coffelt SB, Betancourt AM, Lee CW, et al. Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications. International journal of cancer Journal international du cancer. 2010;127:1741–1747. PubMed PMC

De Y, Chen Q, Schmidt AP, Anderson GM, Wang JM, et al. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. The Journal of experimental medicine. 2000;192:1069–1074. PubMed PMC

Tjabringa GS, Ninaber DK, Drijfhout JW, Rabe KF, Hiemstra PS. Human cathelicidin LL-37 is a chemoattractant for eosinophils and neutrophils that acts via formyl-peptide receptors. International archives of allergy and immunology. 2006;140:103–112. PubMed

Niyonsaba F, Iwabuchi K, Someya A, Hirata M, Matsuda H, et al. A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology. 2002;106:20–26. PubMed PMC

Heilborn JD, Nilsson MF, Kratz G, Weber G, Sorensen O, et al. The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. The Journal of investigative dermatology. 2003;120:379–389. PubMed

Shaykhiev R, Beisswenger C, Kandler K, Senske J, Puchner A, et al. Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure. American journal of physiology Lung cellular and molecular physiology. 2005;289:L842–848. PubMed

Rivas-Santiago B, Hernandez-Pando R, Carranza C, Juarez E, Contreras JL, et al. Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells. Infection and immunity. 2008;76:935–941. PubMed PMC

Klaffenbach D, Friedrich D, Strick R, Strissel PL, Beckmann MW, et al. Contribution of different placental cells to the expression and stimulation of antimicrobial proteins (AMPs). Placenta. 2011;32:830–837. PubMed

Schauber J, Svanholm C, Termen S, Iffland K, Menzel T, et al. Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways. Gut. 2003;52:735–741. PubMed PMC

Hase K, Murakami M, Iimura M, Cole SP, Horibe Y, et al. Expression of LL-37 by human gastric epithelial cells as a potential host defense mechanism against Helicobacter pylori. Gastroenterology. 2003;125:1613–1625. PubMed

Dorschner RA, Lin KH, Murakami M, Gallo RL. Neonatal skin in mice and humans expresses increased levels of antimicrobial peptides: innate immunity during development of the adaptive response. Pediatric research. 2003;53:566–572. PubMed

Mandic Havelka A, Yektaei-Karin E, Hultenby K, Sorensen OE, Lundahl J, et al. Maternal plasma level of antimicrobial peptide LL37 is a major determinant factor of neonatal plasma LL37 level. Acta paediatrica. 2010;99:836–841. PubMed

Zegels G, Van Raemdonck GA, Coen EP, Tjalma WA, Van Ostade XW. Comprehensive proteomic analysis of human cervical-vaginal fluid using colposcopy samples. Proteome science. 2009;7:17. PubMed PMC

IgGFc-binding protein in pregnancies complicated by spontaneous preterm delivery: a retrospective cohort study

Comprehensive proteomic investigation of infectious and inflammatory changes in late preterm prelabour rupture of membranes

Late preterm prelabor rupture of fetal membranes: fetal inflammatory response and neonatal outcome

Proteomic Analysis of Early Mid-Trimester Amniotic Fluid Does Not Predict Spontaneous Preterm Delivery

Maternal Serum C-Reactive Protein in Women with Preterm Prelabor Rupture of Membranes

Potential Peripartum Markers of Infectious-Inflammatory Complications in Spontaneous Preterm Birth